Chinese biotechnology company using industrial fermentation to make bio-based chemicals, including long-chain diacids and bio-based nylon (PA56).
Chinese biotechnology company using industrial fermentation to make bio-based chemicals, including long-chain diacids and bio-based nylon (PA56).
Produces its chemicals by fermentation, growing engineered microbes on plant sugars, and sells them as ingredients to makers of nylon, fragrances, coatings and other materials. Long-chain diacids are the established earner, while bio-based nylon is a newer material still being introduced to textile and plastics customers.
In one line: A Chinese Genomatica/DuPont Tate & Lyle for bio-based materials.
Moat: narrow (IP / patents, process know-how). Proprietary synthetic-biology/fermentation strains and processes that are difficult to replicate.
Headquarters: Shanghai, China · Employees: 1,761
Size Cathay Biotech (688065.SS) is a China Materials company (Chemicals: Specialty) with a market value of $3.77B, the 640th largest of 4,790 China companies the cockpit tracks. Shares closed at CN¥35.12 on 18 Nov 2026.
Performance Over six months the shares fell 23.4%, against -25.6% for the median peer and -20.0% for the China market (cap-weighted) — 9th highest of 21 in its peer set.
Growth Revenue grew 9.4% over the last twelve months (peer median +10.9%); the operating margin is 17.8% (peer median 12.0%).
Valuation It trades at 34.3× forward earnings against a peer median of 14.9× (5th most expensive of 21).
Capital Return on invested capital runs 5.8 points below its cost of capital (9.5% WACC).
Next results Next results expected around 29 Apr 2027 (exchange calendar; dates can move).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | CN¥3.59B | CN¥3.29B | CN¥2.95B | CN¥2.11B | CN¥2.43B |
| Revenue growth | — | +11% | +40% | -13% | — |
| Gross profit | CN¥1.42B | CN¥1.06B | CN¥849M | CN¥554M | CN¥783M |
| EBITDA | n/a | CN¥800M | CN¥676M | CN¥440M | CN¥650M |
| Net income | CN¥637M | CN¥561M | CN¥489M | CN¥367M | CN¥553M |
| Free cash flow | -CN¥270M | -CN¥326M | -CN¥22.4M | -CN¥1.00B | -CN¥3.39B |
| Capital expenditure | CN¥1.03B | CN¥743M | CN¥843M | CN¥1.57B | CN¥4.20B |
| Total debt | CN¥891M | CN¥503M | CN¥1.90B | CN¥1.81B | CN¥1.13B |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
| Company | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g |
|---|---|---|---|---|---|---|
| Cathay Biotech 688065.SS | $3.77B | -23% | +9% | 18% | 34.3× | n/a |
| Evonik Industries EVK.DE | $11.1B | +27% | +2% | 10% | 12.1× | -5.6% |
| Arkema AKE.PA | $4.83B | -3% | -2% | 5% | 13.3× | 12.3% |
| Toray Industries 3402.T | $12.4B | +15% | +10% | 6% | 18.2× | 5.4% |
| Ube 4208.T | $1.94B | +34% | +8% | 5% | 11.9× | n/a |
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | 688065.SS | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | -5.2% | -2.7% | 10th lowest of 21 |
| 6-month return | -23.4% | -25.6% | 9th highest of 21 |
| Distance from 52-week high | -45.5% | -40.6% | 7th lowest of 21 |
| Revenue growth (TTM) | +9.4% | +10.9% | 10th lowest of 21 |
| Operating margin | 17.8% | 12.0% | 6th highest of 21 |
| Forward P/E | 34.3× | 14.9× | 5th most expensive of 21 |
| ROIC minus cost of capital | -5.8 pp | +3.6 pp | lowest of 21 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| Cathay Biotech 688065.SS | China | $3.77B | -23% | +9% | 18% | 34.3× | n/a | n/a |
| Mitsubishi Gas Chemical 4182.T | Japan | $3.76B | -32% | +9% | 9% | 10.2× | n/a | n/a |
| Cabot CBT | United States | $3.80B | -5% | +1% | 14% | 11.3× | -2.3% | +1.9% |
| Bluestar Adisseo 600299.SS | China | $3.70B | -34% | +15% | 13% | 11.3× | -9.4% | +7.7% |
| Hangzhou Oxygen Plant 002430.SZ | China | $3.70B | -16% | +16% | 11% | 19.8× | 2.2% | +8.5% |
| IMEIK Technology Development 300896.SZ | China | $3.66B | -25% | -7% | 45% | 22.4× | 17.5% | +28.0% |
| Do-Fluoride New Materials 002407.SZ | China | $3.62B | -42% | +69% | 7% | 33.9× | 17.3% | +17.5% |
| NOF 4403.T | Japan | $3.60B | -10% | +22% | 17% | 13.6× | -7.4% | +8.4% |
| Pangang Group Vanadium & Titanium Resources 000629.SZ | China | $3.60B | -26% | +6% | 4% | 57.3× | 26.1% | -3.4% |
| GEM 002340.SZ | China | $4.12B | -35% | +2% | 7% | 14.6× | 3.5% | +24.4% |
| Novoray 688300.SS | China | $3.40B | -39% | +23% | 26% | 49.8× | 45.5% | +22.6% |
| Zhejiang Sanmei Chemical Industry 603379.SS | China | $4.20B | -27% | +24% | 41% | 12.2× | 3.8% | +16.5% |
| Clariant CLN.SW | Switzerland | $4.20B | +35% | -7% | 10% | 16.3× | -3.3% | +0.3% |
| Guangxi Huaxi Nonferrous Metal 600301.SS | China | $4.27B | -25% | +24% | 32% | 22.6× | 9.1% | +44.9% |
| Inner Mongolia Berun Chemical 000683.SZ | China | $3.28B | -27% | +11% | 13% | 13.8× | n/a | n/a |
| Ningbo Shanshan 600884.SS | China | $3.27B | -35% | +30% | 9% | 12.2× | 2.8% | +21.3% |
| Air Water 4088.T | Japan | $4.34B | +34% | +11% | 3% | 11.8× | 9.4% | +6.8% |
| Far Eastern New Century 1402.TW | Taiwan | $4.39B | +2% | +5% | 7% | 11.5× | 4.7% | +4.2% |
| Hawkins HWKN | United States | $3.19B | -1% | +9% | 11% | 34.4× | 15.9% | +12.7% |
| Hexpol HPOL-B.ST | Sweden | $3.10B | +19% | -1% | 14% | 15.2× | 2.9% | +7.6% |
| Dottikon ES DESN.SW | Switzerland | $4.63B | -26% | +11% | 27% | 38.2× | 13.4% | +14.4% |